Glenmark has received the Food and Drug Administration’s clearance for olopatadine hydrochloride ophthalmic solution, 0.2% ...

On Monday, 2496 stocks advanced, 1640 declined and 162 remained unchanged on Bombay Stock Exchange with advance decline ratio ...

The product is bioequivalent to Pataday Once Daily Relief Ophthalmic Solution, 0.2% (OTC), developed by Alcon Laboratories, ...

Glenmark receives US FDA final approval for olopatadine hydrochloride ophthalmic solution USP, 0.2%: Our Bureau, Mumbai Friday, March 21, 2025, 12:15 Hrs [IST] Glenmark Pharmaceut ...

Glenmark Pharma's stock rose after it said Glenmark Pharmaceuticals Inc., USA, has received final approval from the USFDA for ...

Glenmark Pharmaceuticals rose 1.95% to Rs 1,506.95 after its US subsidiary, Glenmark Pharmaceuticals Inc., USA, received approval from the US Food & Drug Administration (USFDA) for its Olopatadine ...

Glenmark Pharmaceuticals Ltd on Thursday (March 20) said its arms Pharmaceuticals Inc., USA, has received final approval from the US Food & Drug Administration (USFDA) for its Olopatadine ...

(RTTNews) - Glenmark Pharmaceuticals Inc., USA announced that it has received final approval from the U.S. Food & Drug Administration (FDA) for its Olopatadine Hydrochloride Ophthalmic Solution ...

You can follow us on LinkedIn (Glenmark Pharmaceuticals) and Instagram (glenmark_pharma). 1 Glenmark’s Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC) is only marketed for the ...

Stocks like Lloyds Metals and Energy, Ashoka Buildcon, CG Power and Industrial Solutions, Unichem Laboratories, Happiest ...